Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
1.535
+0.060 (4.07%)
Sep 21, 2026, 11:28 AM HKT
Shanghai Bio-heart Biological Technology Employees
Shanghai Bio-heart Biological Technology had 63 employees as of June 30, 2026. The number of employees decreased by 2 or -3.08% since the number was reported on December 31, 2025.
Employees
63
Change
-2
Growth
-3.08%
Revenue / Employee
704.54K HKD
Profits / Employee
-1.38M HKD
Market Cap
359.04M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 63 | -2 | -3.08% | 63 | 0 |
| Dec 31, 2025 | 65 | 2 | 3.17% | 65 | 0 |
| Dec 31, 2024 | 63 | 31 | 96.88% | 63 | 0 |
| Dec 31, 2023 | 32 | -22 | -40.74% | 32 | 0 |
| Dec 31, 2022 | 54 | 4 | 8.00% | 54 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Uni-Bio Science Group | 568 |
| JW (Cayman) Therapeutics Co. | 303 |
| Cutia Therapeutics | 268 |
| Immunotech Biopharm | 189 |
| 3D Medicines | 162 |
| Transcenta Holding | 150 |
| Kintor Pharmaceutical | 122 |
| Brii Biosciences | 80 |